This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sandostatin LAR

Novartis AG

Drug Names(s): Sandostatin LAR Depot, octreotide acetate

Description: Sandostatin LAR Depot is a long-acting dosage form of Sandostatin using microspheres of a biodegradable polymer.

Deal Structure: BioMedTracker groups Sandostatin and Sandostatin LAR revenue together under Sandostatin LAR.

Sandostatin LAR News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug